A Study in Adult Subjects With Select Advanced Solid Tumors

Completed · Phase 1

Conditions studied: Advanced Solid Tumors

In brief

To evaluate the safety and tolerability of MEDI1873 in adult subjects with selected advanced solid tumors.

Key facts

Study ID

NCT02583165

Run by

MedImmune LLC

People needed

40

Starts

2015-11-09

Expected to finish

2018-12-19

Last updated by the study team

2019-01-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All subjects must consent to provide archived tumor specimen
• Subjects must have histologically or cytologically confirmed advanced solid tumor for recurrent or metastatic disease.
• At the time of Day 1 of the study, subjects with central nervous system (CNS) metastases must have been treated and must be asymptomatic
• Willingness to provide pretreatment and on-treatment biopsies.
• Adequate organ function
• Females of childbearing potential and nonsterilized males who are sexually active must use effective methods of contraception

You may not qualify if…

• Known allergic reaction to any component of MEDI1873
• Concurrent enrollment in another clinical study, unless it is an observational clinical study or the follow-up period of an interventional study
• Receipt of any anticancer therapy within 4 weeks prior to the first dose of MEDI1873; in the case of mAbs, 6 weeks prior to the first dose of MEDI1873
• Any concurrent chemotherapy, immunotherapy, biologic, or hormonal therapy for cancer treatment.
• Receipt of live, attenuated vaccine within 28 days prior to the first dose of investigational product
• Unresolved toxicities from prior anticancer therapy
• Any condition that, in the opinion of the investigator or sponsor, would interfere with evaluation of the investigational product.

Where it is running

• Research Site — Phoenix, Arizona, United States
• Research Site — Scottsdale, Arizona, United States
• Research Site — Los Angeles, California, United States
• Research Site — Tampa, Florida, United States
• Research Site — Rochester, Minnesota, United States
• Research Site — New York, New York, United States
• Research Site — Oklahoma City, Oklahoma, United States
• Research Site — Philadelphia, Pennsylvania, United States
• Research Site — Nashville, Tennessee, United States
• Research Site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.